2026.03. 19 本文字数：1155，阅读时长大约2分钟 作者 | 第一财经 钱童心 3月18日，来自中国科学院广州生物医药与健康研究院以及广州医科大学等中国研究人员发表一项重 磅研究，称他们开发出一种全新的高效线粒体胶囊移植技术，通过将健康的线粒体"打包装箱"到细 胞囊泡中，在国际上首次实现了向细胞和组织的安全高效"快递"。相关成果发表在国际学术期刊 《细胞》发表。 要修复线粒体功能障碍，可以通过将健康的线粒体高效移植到患者体内病变细胞或组织中，从而达到 治疗疾病的效果。但如何植入是一个技术难题。 中国研究团队发现，裸露线粒体移植导入效率低于5%，而使用"线粒体胶囊"投递效率极高，约80% 的目标细胞成功"签收"了供体线粒体。这些线粒体胶囊进入细胞后，还会主动和细胞原有的"发电站 网络"融合在一起，持续发挥功能补偿细胞代谢障碍和功能缺陷。 基于上述发现，研究团队针对多种线粒体DNA突变患者细胞进行测试。结果表明，移植健康的线粒 体后，细胞里原本出现功能障碍的线粒体比例显著下降，濒死的细胞能量代谢迅速恢复。 目前，研究团队已经构建了帕金森病以及线粒体DNA缺失综合征等多个疾病动物模型。在帕金森病 小鼠模 ...

Core Viewpoint - The article discusses a groundbreaking study on mitochondrial transplantation, which presents a new therapeutic approach for mitochondrial diseases and neurodegenerative disorders such as Parkinson's disease, leveraging encapsulated mitochondria for effective treatment [4][6][10]. Group 1: Research Findings - The study developed a new technique for mitochondrial encapsulation, allowing for efficient in vivo transplantation of mitochondria, significantly improving symptoms in models of Parkinson's disease, Leigh syndrome, and mitochondrial DNA depletion syndrome [5][10]. - The research introduces the concept of "organelle therapy," providing a novel treatment strategy for mitochondrial genetic diseases and neurodegenerative disorders [6][10]. - The encapsulation method utilizes red blood cell membranes to create "mitochondrial capsules," which protect the mitochondria and enhance their delivery into recipient cells, achieving a transplantation efficiency of approximately 80% compared to less than 5% for bare mitochondria [7][10]. Group 2: Implications and Applications - Mitochondrial transplantation can repair mitochondrial defects in patient-derived cells and is effective in treating mitochondrial DNA depletion syndrome and Leigh syndrome [8][10]. - In mouse models of Parkinson's disease, mitochondrial transplantation effectively prevented neuronal death and restored normal mitochondrial function, significantly improving motor abilities [10][11]. - This organelle therapy approach offers a more precise strategy compared to traditional cell therapies, potentially benefiting a wide range of diseases associated with mitochondrial dysfunction, including neurodegenerative diseases and metabolic disorders [10][11].